A recent study using adeno-associated virus 2 (AAV2) carrying Fdxr as a gene transfer vector in a mouse model carrying a variant in Fdxr showed significant improvement in optic atrophy, sensory neuropathy, and mitochondrial dysfunction, thus indicating a potential strategy of intervention [4]. This evidence concerns the gene FDXR and Sensory neuropathy.